IP Library Granted Patent US 10,092,293
Granted Patent B2
US 10,092,293 · App. 15/344,998 · Granted Oct 9, 2018

Graft apparatus

Inventors: Peter P. Zilla (Cape Town, ZA); Nasser Rafiee (Andover, MA); Deon Bezuidenhout (Cape Town, ZA); Thomas Franz (Devils Peak, ZA); Mark Yeoman (East Sussex, GB); Hellmut C. Bowles (Bloubergrant, ZA); Nareak Douk (Lowell, MA); Michael F. Wolf (Golden Valley, MN); Paul Human (Cape Town, ZA)
Assignee: Neograft Technologies, Inc.
A61B17/11A61F2/06A61F2/07A61F2/856A61B2017/1107A61B2017/1132A61B2017/1135A61F2/90A61F2/95
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,092,293
App. No.
15/344,998
Granted
Oct 9, 2018
Kind
B2
Abstract

Stents and methods of using stents are provided. Stents of the invention provide external support structure for a blood vessel segment disposed within, wherein the stents are capable of resilient radial expansion in a manner mimicking the compliance properties of an artery. The stent may be formed of a knitted or braided mesh formed so as to provide the needed compliance properties. A venous graft with the stent and a vein segment disposed within is provided, wherein graft is capable of mimicking the compliance properties of an artery. Methods of selecting stents for downsizing and methods of using the stents of the invention in downsizing and smoothening are provided. Methods of replacing a section of an artery with a venous graft including a stent of the invention are provided. Methods of reducing intimal hyperplasia in implanted vein segment in a venous graft using stents of the invention are provided.

Claims (9)

1. A bioprosthetic apparatus for use with an arteriovenous connection, the bioprosthetic apparatus comprising a generally tubular, radially resilient external support and a vessel segment carried within and having an ablumenal surface in contact with and supported by the external support, wherein the external support has resilient radial expansion and contraction characteristics that provide the apparatus with a compliance ranging from 3-30%/100 mm Hg, the apparatus being adapted for providing repeated exterior access to a patient's vascular system.

2. The bioprosthetic apparatus according to claim 1 , wherein the external support exerts a radially resilient contraction force that is sufficient to close a puncture wound caused by penetration of the vessel by a needle.

3. The bioprosthetic apparatus according to claim 1 , wherein the vessel segment comprises at least a portion of a bovine artery or at least a portion of a porcine artery.

4. The bioprosthetic apparatus according to claim 1 , wherein at least a portion of the vessel segment is treated with an aldehyde fixative.

5. The bioprosthetic apparatus according to claim 1 , wherein at least a portion of the vessel segment is decellularized.

6. The bioprosthetic apparatus according to claim 1 , wherein the external support comprises a braided support.

7. The bioprosthetic apparatus according to claim 1 , wherein the external support comprises one or more loops, one or more openings, or a combination thereof constructed and arranged to receive a needle.

8. The bioprosthetic apparatus according to claim 7 , wherein the external support comprises the one or more loops, and wherein a diameter of the one or more loops is between about 1.8 mm and about 2.1 mm.

9. The bioprosthetic apparatus according to claim 7 , wherein the external support comprises the one or more openings, and wherein a diameter of the one or more openings is between about 1.8 mm and about 2.1 mm.

Assignments (7)
SECURITY INTEREST Recorded Apr 22, 2020
From: VASCULAR GRAFT SOLUTIONS LTD.
To: PONTIFAX MEDISON FINANCE (ISRAEL) LIMITED PARTNERSHIP; PONTIFAX MEDISON FINANCE (CAYMAN) LIMITED PARTNERSHIP
Reel/Frame 052469/0719 →
SECURITY INTEREST Recorded Apr 22, 2020
From: VASCULAR GRAFT SOLUTIONS LTD.
To: PONTIFAX MEDISON FINANCE (ISRAEL) LIMITED PARTNERSHIP; PONTIFAX MEDISON FINANCE (CAYMAN) LIMITED PARTNERSHIP
Reel/Frame 052469/0968 →
SECURITY INTEREST Recorded Apr 22, 2020
From: VASCULAR GRAFT SOLUTIONS LTD.
To: PONTIFAX MEDISON FINANCE (ISRAEL) LIMITED PARTNERSHIP; PONTIFAX MEDISON FINANCE (CAYMAN) LIMITED PARTNERSHIP
Reel/Frame 052469/0878 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 21, 2019
From: NEOGRAFT TECHNOLOGIES, INC.
To: VASCULAR GRAFT SOLUTIONS LTD.
Reel/Frame 051075/0555 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2016
From: ZILLA, PETER PAUL; RAFIEE, NASSER; BEZUIDENHOUT, DEON; FRANZ, THOMAS; YEOMAN, MARK; BOWLES, HELLMUT; DOUK, NAREAK; WOLF, MICHAEL F.
To: MEDTRONIC, INC.
Reel/Frame 040651/0871 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2016
From: KIPS BAY MEDICAL, INC.
To: NEOGRAFT TECHNOLOGIES, INC.
Reel/Frame 040651/0885 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2016
From: MEDTRONIC, INC.
To: KIPS BAY MEDICAL, INC.
Reel/Frame 040651/0881 →
Continuity (9)
Division 14448694 · Jul 31, 2014
Continuation 14048864 · Oct 8, 2013
Division 13745999 · Jan 21, 2013
Continuation 13209517 · Aug 15, 2011
Continuation 11797648 · May 4, 2007
Continuation In Part 10987313 · Nov 12, 2004
Continuation In Part 10834360 · Apr 28, 2004
Provisional Application 60466226 · Apr 28, 2003
Related Publication 20170296192A1 · Oct 19, 2017